BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 25268601)

  • 1. New therapeutic options for actinic keratosis and basal cell carcinoma.
    Sligh JE
    Semin Cutan Med Surg; 2014 Jun; 33(4 Suppl):S76-80. PubMed ID: 25268601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imiquimod induces sustained remission of actinic damage: a case report spanning one decade of observation.
    Knackstedt TJ; Quitadamo M
    Cutis; 2015 Feb; 95(2):E20-3. PubMed ID: 25750973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imiquimod and lymphatic field clearance: a new hypothesis based on a remote immune action on skin cancer.
    Akkilic-Materna M; Massone C; Komericki P
    Acta Derm Venereol; 2011 Jun; 91(4):432-5. PubMed ID: 21547348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Field cancerization: from molecular basis to selective field-directed management of actinic keratosis.
    Philipp-Dormston WG
    Curr Probl Dermatol; 2015; 46():115-21. PubMed ID: 25561215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ingenol mebutate: an introduction.
    Fallen RS; Gooderham M
    Skin Therapy Lett; 2012 Feb; 17(2):1-3. PubMed ID: 22358305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient Perception of Imiquimod Treatment for Actinic Keratosis and Superficial Basal Cell Carcinoma in 202 Patients.
    Waalboer-Spuij R; Holterhues C; van Hattem S; Schuttelaar ML; Gaastra MT; Kuijpers DI; Hollestein LM; Nijsten TE
    Dermatology; 2015; 231(1):56-62. PubMed ID: 25925162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of ingenol mebutate 0.015% gel after cryosurgery of actinic keratosis: 12-month results.
    Berman B; Goldenberg G; Hanke CW; Tyring SK; Werschler WP; Knudsen KM; Larsson T; Swanson N
    J Drugs Dermatol; 2014 Jun; 13(6):741-7. PubMed ID: 24918567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of ingenol mebutate 0.015% gel 3 weeks after cryosurgery of actinic keratosis: 11-week results.
    Berman B; Goldenberg G; Hanke CW; Tyring SK; Werschler WP; Knudsen KM; Goncalves J; Larsson T; Skov T; Swanson N
    J Drugs Dermatol; 2014 Feb; 13(2):154-60. PubMed ID: 24509965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of ingenol mebutate gel for actinic keratosis in patients in a community dermatology practice.
    Bettencourt MS
    J Drugs Dermatol; 2014 Mar; 13(3):269-73. PubMed ID: 24595570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Photodynamic therapy vs imiquimod].
    Serra-Guillén C; Nagore E; Guillén C
    Actas Dermosifiliogr; 2012; 103(6):488-501. PubMed ID: 22178262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ivacaftor, vismodegib, and ingenol mebutate.
    Hussar DA; Eckel SP
    J Am Pharm Assoc (2003); 2012; 52(3):418-22. PubMed ID: 22618984
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of ingenol mebutate on actinic keratosis in a Korean population: A prospective clinical, dermoscopic and histopathological study from a single center.
    Kim JS; Woo YR; Kim M; Park HJ
    J Dermatol; 2018 Nov; 45(11):1324-1330. PubMed ID: 30260493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-melanoma Skin Cancer in Canada Chapter 3: Management of Actinic Keratoses.
    Poulin Y; Lynde CW; Barber K; Vender R; Claveau J; Bourcier M; Ashkenas J;
    J Cutan Med Surg; 2015; 19(3):227-38. PubMed ID: 25926621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Field Treatment of Actinic Keratosis With Ingenol Mebutate Gel on the Identification of Lesions for Biopsy.
    Bettencourt MS
    J Drugs Dermatol; 2015 Aug; 14(8):813-8. PubMed ID: 26267725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of imiquimod in the treatment of periocular tumours.
    Ross AH; Kennedy CT; Collins C; Harrad RA
    Orbit; 2010 Apr; 29(2):83-7. PubMed ID: 20394545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beyond a decade of 5% imiquimod topical therapy.
    A Gaspari A; Tyring SK; Rosen T
    J Drugs Dermatol; 2009 May; 8(5):467-74. PubMed ID: 19537370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of apoptosis-associated molecules Erythroid differentiation regulator 1, bcl-2 and p53 in actinic keratosis after treatment with ingenol mebutate.
    Woo YR; Lim JH; Jeong SW; Cho DH; Park HJ
    Exp Dermatol; 2017 Nov; 26(11):1012-1017. PubMed ID: 28370377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Imiquimod cream. A cream to use with precaution].
    Taeron C
    Rev Infirm; 2010 Jun; (161):47-9. PubMed ID: 20536098
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of Basal Cell Carcinoma in the Elderly: What Nondermatologists Need to Know.
    Wiznia LE; Federman DG
    Am J Med; 2016 Jul; 129(7):655-60. PubMed ID: 27046242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of life and side effects in patients with actinic keratosis treated with ingenol mebutate: a pilot study.
    Jubert-Esteve E; Del Pozo-Hernando LJ; Izquierdo-Herce N; Bauzá-Alonso A; Martín-Santiago A; Jones-Caballero M
    Actas Dermosifiliogr; 2015 Oct; 106(8):644-50. PubMed ID: 26130156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.